Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Clearside Biomedical, Inc. (CLSD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.47000.0000 (0.00%)
At close: 04:00PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/29/2022
Current
3/31/202212/31/20219/30/20216/30/2021
Market Cap (intraday)
92.03M137.74M164.24M357.76M287.78M
Enterprise Value
58.25M107.98M139.78M332.18M262.55M
Trailing P/E
153.00229.00N/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
3.114.6439.3874.2963.02
Price/Book (mrq)
2.903.639.2018.5016.94
Enterprise Value/Revenue
1.95311.175.44108.06336.60
Enterprise Value/EBITDA
228.43-14.217.45-68.56-43.38

Trading Information

Stock Price History

Beta (5Y Monthly) 2.18
52-Week Change 3-73.47%
S&P500 52-Week Change 3-11.93%
52 Week High 37.7300
52 Week Low 31.2600
50-Day Moving Average 31.4696
200-Day Moving Average 32.8640

Share Statistics

Avg Vol (3 month) 3241.65k
Avg Vol (10 day) 3194.24k
Shares Outstanding 560.15M
Implied Shares Outstanding 6N/A
Float 850.91M
% Held by Insiders 111.03%
% Held by Institutions 135.76%
Shares Short (Jun 14, 2022) 4943.99k
Short Ratio (Jun 14, 2022) 45.51
Short % of Float (Jun 14, 2022) 41.73%
Short % of Shares Outstanding (Jun 14, 2022) 41.57%
Shares Short (prior month May 12, 2022) 41.66M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.28%
Operating Margin (ttm)0.25%

Management Effectiveness

Return on Assets (ttm)0.15%
Return on Equity (ttm)0.34%

Income Statement

Revenue (ttm)29.89M
Revenue Per Share (ttm)0.50
Quarterly Revenue Growth (yoy)920.60%
Gross Profit (ttm)29.57M
EBITDA 255k
Net Income Avi to Common (ttm)83k
Diluted EPS (ttm)0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)34.37M
Total Cash Per Share (mrq)0.57
Total Debt (mrq)591k
Total Debt/Equity (mrq)1.86
Current Ratio (mrq)8.49
Book Value Per Share (mrq)0.53

Cash Flow Statement

Operating Cash Flow (ttm)-1.3M
Levered Free Cash Flow (ttm)-1.07M
Advertisement
Advertisement